Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
NPJ Digital Medicine
|
July 9, 2026
Automated risk scoring for venous thromboembolism using large language models with expert knowledge-augmented prompting: a multicenter validation study
Jing Ma, Dingyi Wang, Yaqian Zhang, et al.
Lancet (London, England)
|
January 28, 2020
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li, et al.
Ebiomedicine
|
November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Yeming Wang, Wu Zhong, Alex Salam, et al.
Lancet (London, England)
|
June 15, 2023
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang, Lixue Huang, Yeming Wang, et al.
Lancet (London, England)
|
January 11, 2021
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang, Lixue Huang, Yeming Wang, et al.
Thrombosis and Haemostasis
|
June 24, 2025
Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2
Yuzhi Tao, Hong Chen, Chunling Dong, et al.
The Lancet Regional Health. Western Pacific
|
February 3, 2025
Corrigendum to "Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study", [The Lancet Regional Health - Western Pacific, Volume 54, January 2025, 101258]
Kaiyuan Zhen, Yuzhi Tao, Lei Xia, et al.
The Lancet Regional Health. Western Pacific
|
January 6, 2025
Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study
Kaiyuan Zhen, Yuzhi Tao, Lei Xia, et al.
Lancet (London, England)
|
May 20, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang, Dingyu Zhang, Guanhua Du, et al.
COPD
|
April 6, 2022
Development and Validation of a Screening Questionnaire of COPD from a Large Epidemiological Study in China
Dingyi Wang, Guohui Fan, Sinan Wu, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
NPJ Digital Medicine
|
July 9, 2026
Automated risk scoring for venous thromboembolism using large language models with expert knowledge-augmented prompting: a multicenter validation study
Jing Ma, Dingyi Wang, Yaqian Zhang, et al.
Lancet (London, England)
|
January 28, 2020
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li, et al.
Ebiomedicine
|
November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Yeming Wang, Wu Zhong, Alex Salam, et al.
Lancet (London, England)
|
June 15, 2023
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang, Lixue Huang, Yeming Wang, et al.
Lancet (London, England)
|
January 11, 2021
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang, Lixue Huang, Yeming Wang, et al.
Thrombosis and Haemostasis
|
June 24, 2025
Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2
Yuzhi Tao, Hong Chen, Chunling Dong, et al.
The Lancet Regional Health. Western Pacific
|
February 3, 2025
Corrigendum to "Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study", [The Lancet Regional Health - Western Pacific, Volume 54, January 2025, 101258]
Kaiyuan Zhen, Yuzhi Tao, Lei Xia, et al.
The Lancet Regional Health. Western Pacific
|
January 6, 2025
Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study
Kaiyuan Zhen, Yuzhi Tao, Lei Xia, et al.
Lancet (London, England)
|
May 20, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang, Dingyu Zhang, Guanhua Du, et al.
COPD
|
April 6, 2022
Development and Validation of a Screening Questionnaire of COPD from a Large Epidemiological Study in China
Dingyi Wang, Guohui Fan, Sinan Wu, et al.
Page
of 9